Biomesocarb-oxy therapy

Objectives: Upon completion of this presentation, participants will have a better understanding of the role of Biomesocarboxytherapy as a complementary treatment following body contouring surgery. They will be able to describe its potential impact on postoperative tissue remodeling, skin quality, wound healing, and scar maturation; interpret clinical outcomes using validated assessment tools, including VAS, P-GAIS, I-GAIS, and POSAS; and critically evaluate the current evidence supporting its use to optimize aesthetic and functional surgical outcomes while recognizing the need for further research Introduction: Body contouring procedures following weight loss often present challenges related to skin quality, tissue laxity, wound healing, and scar maturation. Adjunctive therapies aimed at improving tissue regeneration and optimizing postoperative recovery may enhance both functional and aesthetic outcomes. This study evaluated the effectiveness of Biomesocarboxytherapy as a complementary treatment in body surgery patients. Materials / method: A prospective observational study was conducted on patients undergoing body contouring surgery. Biomesocarboxytherapy was administered according to a standardized postoperative treatment protocol. Clinical outcomes were evaluated using the Visual Analog Scale (VAS), the Patient Global Aesthetic Improvement Scale (P-GAIS), the Investigator Global Aesthetic Improvement Scale (I-GAIS), and the Patient and Observer Scar Assessment Scale (POSAS). Tissue firmness, skin remodeling, postoperative recovery, and scar maturation were assessed throughout the follow-up period. Results: Patients receiving adjunctive Biomesocarboxytherapy demonstrated consistent improvements in tissue firmness and skin quality during postoperative recovery. Enhanced tissue remodeling and faster maturation of the operated tissues were observed, contributing to improved healing after body contouring surgery. Surgical scars showed favorable evolution, with improved POSAS scores. Both patient- and investigator-reported assessments (P-GAIS and I-GAIS) demonstrated high levels of aesthetic improvement and satisfaction, while VAS scores reflected a favorable postoperative recovery. Conclusion: Biomesocarboxytherapy appears to be a valuable complementary treatment for optimizing outcomes after body contouring surgery. The observed improvements in tissue firmness, postoperative tissue maturation, and surgical scar quality suggest that this approach may enhance both aesthetic and functional recovery. Further randomized controlled studies with larger patient cohorts are needed to confirm these findings and define evidence-based treatment protocols.